Mineralocorticoid receptor antagonist use after hospitalization of patients with heart failure and post-discharge outcomes: a single-center retrospective cohort study

BACKGROUND: Mineralocorticoid receptor antagonists (MRA) are an underutilized therapy for heart failure with a reduced ejection fraction (HFrEF), but the current impact of hospitalization on MRA use is not well characterized. The objective of this study was to describe contemporary MRA prescription...

Descripción completa

Detalles Bibliográficos
Autores principales: Durstenfeld, Matthew S., Katz, Stuart D., Park, Hannah, Blecker, Saul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688376/
https://www.ncbi.nlm.nih.gov/pubmed/31399059
http://dx.doi.org/10.1186/s12872-019-1175-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688376/
https://www.ncbi.nlm.nih.gov/pubmed/31399059
http://dx.doi.org/10.1186/s12872-019-1175-3

Ejemplares similares